GIANT BioSystems is a developer of an ultra-fast, next-generation platform for AST and high-throughput drug screening.
GIANT BioSystems has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.
GIANT BioSystems's investors include NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR).
GIANT BioSystems is headquartered in Los Angeles, United States.
GIANT BioSystems is a developer of an ultra-fast, next-generation platform for AST and high-throughput drug screening.
GIANT BioSystems is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GIANT BioSystems — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/giant-biosystems. Accessed August 14, 2026.
VCBacked. (2025). GIANT BioSystems — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/giant-biosystems
{{cite web |title=GIANT BioSystems — Funding & Investors |url=https://www.vcbacked.co/company/giant-biosystems |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated